Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
CALCIUM CARBONATE COLECALCIFEROL
Rottapharm Ltd
600/400IU Base Milligrams
Tablets Chewable
2000-11-10
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT CALVIDIN ® 600 mg/400 I.U. chewable tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each chewable tablet contains: Calcium carbonate 1500 mg equivalent to elemental calcium 600 mg Cholecalciferol concentrate (powder form) 4 mg equivalent to vitamin D 3 10 µg (400 I. U.) Excipient: Sucrose 1,54 mg For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Chewable tablet White biplane tablets with a snap grove and the letters C/D. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Correction of combined vitamin D and calcium deficiencies in the elderly. Supply of vitamin D and calcium as an adjunct to specific treatments for osteoporosis, in patients where combined vitamin D and calcium deficiencies have been diagnosed or those at a high risk of such deficiency. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Adults and elderly One chewable tablet twice a day [e. g. one tablet in the morning and one tablet in the evening (equivalent to 1200 mg of calcium and 800 I.U. of vitamin D 3 )]. Dose reduction should be considered as necessary following the monitoring of calcium levels as indicated in section 4.4 and 4.5. Pregnant women One chewable tablet a day (see section 4.6). Posology in cases of hepatic insufficiency The dose does not require adjustment. Posology in cases of renal insufficiency Dosage in renal impairment: CALVIDIN ® chewable tablets should not be used in patients with severe renal impairment. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 16/01/2012_ _CRN 2104961_ _page number: 1_ The tablets are chewed and then swallowed with a little liquid. In exceptional cases (e.g. patients disabled) the tablets can, Read the complete document